Effect of Copolymer Properties on the Phase Behavior of Ibuprofen–PLA/PLGA Mixtures

Prediction of compatibility of the active pharmaceutical ingredient (API) with the polymeric carrier plays an essential role in designing drug delivery systems and estimating their long-term physical stability. A key element in deducing API–polymer compatibility is knowledge of a complete phase diag...

Full description

Bibliographic Details
Main Authors: Anton Iemtsev, Martin Klajmon, Fatima Hassouna, Michal Fulem
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/15/2/645
_version_ 1797618695441219584
author Anton Iemtsev
Martin Klajmon
Fatima Hassouna
Michal Fulem
author_facet Anton Iemtsev
Martin Klajmon
Fatima Hassouna
Michal Fulem
author_sort Anton Iemtsev
collection DOAJ
description Prediction of compatibility of the active pharmaceutical ingredient (API) with the polymeric carrier plays an essential role in designing drug delivery systems and estimating their long-term physical stability. A key element in deducing API–polymer compatibility is knowledge of a complete phase diagram, i.e., the solubility of crystalline API in polymer and mutual miscibility of API and polymer. In this work, the phase behavior of ibuprofen (IBU) with different grades of poly(D,L-lactide-co-glycolide) (PLGA) and polylactide (PLA), varying in composition of PLGA and molecular weight of PLGA and PLA, was investigated experimentally using calorimetry and computationally by the perturbed-chain statistical associating fluid theory (PC-SAFT) equation of state (EOS). The phase diagrams constructed based on a PC-SAFT EOS modeling optimized using the solubility data demonstrated low solubility at typical storage temperature (25 °C) and limited miscibility (i.e., presence of the amorphous–amorphous phase separation region) of IBU with all polymers studied. The ability of PC-SAFT EOS to capture the experimentally observed trends in the phase behavior of IBU–PLA/PLGA systems with respect to copolymer composition and molecular weight was thoroughly investigated and evaluated.
first_indexed 2024-03-11T08:17:08Z
format Article
id doaj.art-9aa3842d772241d2b2b99e703e35ffc7
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-11T08:17:08Z
publishDate 2023-02-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-9aa3842d772241d2b2b99e703e35ffc72023-11-16T22:42:43ZengMDPI AGPharmaceutics1999-49232023-02-0115264510.3390/pharmaceutics15020645Effect of Copolymer Properties on the Phase Behavior of Ibuprofen–PLA/PLGA MixturesAnton Iemtsev0Martin Klajmon1Fatima Hassouna2Michal Fulem3Department of Physical Chemistry, University of Chemistry and Technology, Prague, Technická 5, 166 28 Prague, Czech RepublicDepartment of Physical Chemistry, University of Chemistry and Technology, Prague, Technická 5, 166 28 Prague, Czech RepublicFaculty of Chemical Engineering, University of Chemistry and Technology, Prague, Technická 5, 166 28 Prague, Czech RepublicDepartment of Physical Chemistry, University of Chemistry and Technology, Prague, Technická 5, 166 28 Prague, Czech RepublicPrediction of compatibility of the active pharmaceutical ingredient (API) with the polymeric carrier plays an essential role in designing drug delivery systems and estimating their long-term physical stability. A key element in deducing API–polymer compatibility is knowledge of a complete phase diagram, i.e., the solubility of crystalline API in polymer and mutual miscibility of API and polymer. In this work, the phase behavior of ibuprofen (IBU) with different grades of poly(D,L-lactide-co-glycolide) (PLGA) and polylactide (PLA), varying in composition of PLGA and molecular weight of PLGA and PLA, was investigated experimentally using calorimetry and computationally by the perturbed-chain statistical associating fluid theory (PC-SAFT) equation of state (EOS). The phase diagrams constructed based on a PC-SAFT EOS modeling optimized using the solubility data demonstrated low solubility at typical storage temperature (25 °C) and limited miscibility (i.e., presence of the amorphous–amorphous phase separation region) of IBU with all polymers studied. The ability of PC-SAFT EOS to capture the experimentally observed trends in the phase behavior of IBU–PLA/PLGA systems with respect to copolymer composition and molecular weight was thoroughly investigated and evaluated.https://www.mdpi.com/1999-4923/15/2/645biodegradable polymersPLGAPLAamorphous solid dispersionAPI–polymer compatibilityPC-SAFT
spellingShingle Anton Iemtsev
Martin Klajmon
Fatima Hassouna
Michal Fulem
Effect of Copolymer Properties on the Phase Behavior of Ibuprofen–PLA/PLGA Mixtures
Pharmaceutics
biodegradable polymers
PLGA
PLA
amorphous solid dispersion
API–polymer compatibility
PC-SAFT
title Effect of Copolymer Properties on the Phase Behavior of Ibuprofen–PLA/PLGA Mixtures
title_full Effect of Copolymer Properties on the Phase Behavior of Ibuprofen–PLA/PLGA Mixtures
title_fullStr Effect of Copolymer Properties on the Phase Behavior of Ibuprofen–PLA/PLGA Mixtures
title_full_unstemmed Effect of Copolymer Properties on the Phase Behavior of Ibuprofen–PLA/PLGA Mixtures
title_short Effect of Copolymer Properties on the Phase Behavior of Ibuprofen–PLA/PLGA Mixtures
title_sort effect of copolymer properties on the phase behavior of ibuprofen pla plga mixtures
topic biodegradable polymers
PLGA
PLA
amorphous solid dispersion
API–polymer compatibility
PC-SAFT
url https://www.mdpi.com/1999-4923/15/2/645
work_keys_str_mv AT antoniemtsev effectofcopolymerpropertiesonthephasebehaviorofibuprofenplaplgamixtures
AT martinklajmon effectofcopolymerpropertiesonthephasebehaviorofibuprofenplaplgamixtures
AT fatimahassouna effectofcopolymerpropertiesonthephasebehaviorofibuprofenplaplgamixtures
AT michalfulem effectofcopolymerpropertiesonthephasebehaviorofibuprofenplaplgamixtures